Elora Price range: $70 through $125Select options
Same-day UPS Air Express from Texas · Ships free over $200 · Overnight option available
Call or text 770-335-0683
Free express shipping over $200 from Texas
Weight Loss
Elora
Lab tested 99.86% pureLab sheet
Storage2-8c
from $70
Select Vial size
Quick pick
Volume pricing
2–2 vials5% off
3–4 vials10% off
5–9 vials25% off
10–999 vials40% off
Certificate of Analysis
Most recent lab test
99.86%
Purity
4.42 mg
Tested mass · 5 mg labeled · -11.6%
Test panel
Identity confirmed · ConfirmedHeavy metals · PassSterility · No growthMicrobial (PCR) · PassEndotoxin · PassFentanyl screen · Not detectedAppearance · White Lyophilized Powder
Lot 105-01-RB · Search code Pept2607240067
Verify this COA at Freedom Diagnostics
Search code
Pept2607240067
- Copy the code above.
- Open the Freedom Diagnostics lookup.
- Paste it into the search field and hit enter.
For laboratory and research use only. Not for human or veterinary use, not a drug, food, or cosmetic.
Amylin Receptor Agonist · Metabolic & Weight
Elora. A selective amylin receptor agonist for metabolic and weight-management research.
Elora (Eloralintide) is an investigational long-acting amylin receptor agonist, researched for appetite regulation, satiety, and body-weight endpoints. Offered in 5mg and 10mg vials — select your size below and the details update to match.
Select vial size:
Selected Vial
You're viewing the 5mg vial — the standard research amount. It's a fitting entry point for baseline study designs, dose-finding work, and protocols that call for a smaller quantity of peptide per vial.
You're viewing the 10mg vial — the higher-capacity option. It delivers twice the peptide per vial, suited to extended studies, higher-amount protocols, and research programs that prefer fewer reorders.
Amylin Pathway
A selective amylin receptor agonist, studied for satiety and appetite regulation.
Vial Size
5mg10mg of Eloralintide per vial. No filler, no blend, single compound.
Lab-Ready Vial
Lyophilized, third-party HPLC tested, with a COA on this page.
WHAT'S IN THE VIAL
One amylin agonist. One target pathway. One vial.
Amylin Agonist
5mg
Elora
Selective amylin receptor agonist
An investigational long-acting amylin analog. The 5mg vial is the standard research amount, sized for baseline and dose-finding study designs.
Amylin Agonist
10mg
Elora
Selective amylin receptor agonist
An investigational long-acting amylin analog. The 10mg vial is the higher-capacity option, twice the peptide per vial for extended or higher-amount research.
Amylin is a hormone co-secreted with insulin by the pancreas that signals satiety and slows the pace of digestion. Eloralintide is studied as a selective agonist of the amylin receptor, designed to act on that pathway in a long-acting form. Whichever vial size you choose, the peptide inside is the same Eloralintide; the only difference between the 5mg and 10mg is the amount per vial.
What Eloralintide Brings
Eloralintide is an investigational selective amylin receptor agonist, a peptide designed to activate the amylin pathway that the body uses to signal fullness and regulate the pace of digestion. It sits in the same broad research area as other amylin-based approaches to appetite and body-weight regulation, and it is being developed as a long-acting agonist intended for infrequent dosing in a research setting.
The proposed mechanism is centered on satiety. Amylin, released alongside insulin after a meal, acts on receptors in the brain to promote a feeling of fullness, slows gastric emptying so that digestion proceeds more gradually, and helps moderate the release of glucagon. By selectively engaging the amylin receptor, Eloralintide is researched for its ability to reproduce and extend these signals, with appetite regulation and body-weight endpoints as the primary focus.
Interest in selective amylin receptor agonists comes from the broader research into metabolic and weight-management peptides, where amylin-pathway compounds are studied both on their own and as complements to other mechanisms. Eloralintide is one of the newer entries in that space, characterized by its selectivity for the amylin receptor.
ONE PEPTIDE, ONE PATHWAY
Satiety→ Amylin-receptor signaling of fullness in the central nervous system
Gastric→ Slowed gastric emptying, more gradual digestion
Metabolic→ Moderation of glucagon, appetite and body-weight endpoints
One selective amylin receptor agonist, studied across the satiety, gastric, and metabolic sides of appetite regulation.
5mg vs 10mg
Both vials contain the same Eloralintide peptide. The only difference is the amount per vial, so the choice is about your research quantity, not the compound itself. Your current selection is highlighted below.
Standard
5mg
The standard research amount. Best for baseline study designs, dose-finding, and smaller protocols.
Higher Capacity
10mg
Twice the peptide per vial. Best for extended studies, higher-amount protocols, and fewer reorders.
What's in the Vial
One lyophilized vial containing 5mg of Eloralintide, a selective amylin receptor agonist, with no blend and no additional compounds. Tested for purity by third-party HPLC analysis. COA available on this product page.
One lyophilized vial containing 10mg of Eloralintide, a selective amylin receptor agonist, with no blend and no additional compounds. Tested for purity by third-party HPLC analysis. COA available on this product page.
Why Researchers Use Eloralintide
- A selective agonist of the amylin receptor, a focused single-pathway target
- Investigational long-acting amylin analog designed for infrequent dosing
- Studied for satiety, appetite regulation, and body-weight endpoints
- Slows gastric emptying and moderates glucagon in the research model
- Part of the modern metabolic and weight-management peptide research space
- Offered in two vial sizes so quantity matches the study design
- 5mg of Eloralintide per vial, the standard research amount
- 10mg of Eloralintide per vial, the higher-capacity option
About the Name
We call it Elora, a clean shorthand for the compound's full designation, Eloralintide. The "-lintide" ending of the full name reflects its amylin lineage, echoing the naming of other amylin-pathway peptides. Elora keeps the everyday reference simple while the full name Eloralintide ties it precisely to the literature the compound appears in.
Research Context
Eloralintide is an investigational selective amylin receptor agonist under development in the metabolic and weight-management space. As a newer compound, its research base is early, and its data sits within clinical development rather than a long-established literature. It is not approved by the FDA for general human use, and its safety and efficacy profile is still being characterized. Researchers working with Eloralintide are engaging a current-generation amylin-pathway peptide at the frontier of metabolic research, where the mechanism is well understood but the compound-specific evidence base is still being built.
Storage
Store the lyophilized product refrigerated and away from light. Keep sealed and protected from moisture until use. Do not freeze.
Product Highlights
- 5mg Eloralintide per vial (standard amount)
- 10mg Eloralintide per vial (higher capacity)
- Selective amylin receptor agonist
- Investigational long-acting amylin analog
- Studied for satiety and appetite regulation
- Slowed gastric emptying, metabolic endpoints
- Single compound, no blend
- Third-party HPLC tested
- COA available on product page
- Lyophilized for shelf stability
For Research Use Only. Eloralintide is an investigational research compound. It is not approved by the FDA for general human use. Safety and efficacy in humans have not been established. This product is sold strictly for laboratory and research purposes. Not for human consumption.